#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Short stature homeobox gene mutation Juvenile idiopathic arthritis Marginal zone lymphoma recurrent Desmoid tumour Kearns-Sayre syndrome Leukodystrophy Heavy menstrual bleeding Hereditary ataxia Palmar-plantar erythrodysaesthesia syndrome Warm autoimmune haemolytic anaemia Insulinoma Angiosarcoma non-metastatic Loeys-Dietz syndrome B-cell small lymphocytic lymphoma refractory Pancreatic carcinoma More trials…

    Learn about Rare Diseases

    Breast angiosarcoma metastatic – Treatment Mitochondrial myopathy Congenital hypotransferrinaemia – Basic Information Breast angiosarcoma Rhabdomyosarcoma – Treatment Osteosarcoma – Basic Information Wiskott-Aldrich syndrome – Basic Information Mantle cell lymphoma Uterine leiomyosarcoma Langerhans cell sarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Haloperidol Piperacillin Monohydrate Tazobactam Abbv-668 Sufentanil Citrate Efmoroctocog Alfa MB-HUCART19.1 Terbinafine Hydrochloride Dorzolamide Vibozilimod Saline Lasofoxifene Ly3537982 L-Histidine Hydrochloride Darbepoetin Alfa Ro7589655 Iomeprol Triptorelin Pamoate Dacarbazine Ale.c04 More therapies…

    Learn about Your Condition

    Mucous membrane pemphigoid Colon cancer metastatic Dyskinesia Papulopustular rosacea CADASIL Peritoneal neoplasm Emphysema Ligament operation Adenocarcinoma pancreas Pancreatitis acute Mitral valve disease Foetal growth restriction Ear discomfort Systemic sclerosis pulmonary Periodontitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Increasing the dose of glimepiride for patients with HNF1A-MODY or HNF4A-MODY diabetes

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Monogenic diabetes
    Investigated Drugs:
    • Glimepiride
    Denmark

  • Evaluating the effect of recombinant varicella zoster virus glycoprotein E vaccine on heart problems and dementia in adults aged 65 years or older with herpes zoster

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Herpes zoster
    Investigated Drugs:
    • Recombinant Varicella Zoster Virus Glycoprotein E
    Denmark

  • Study to evaluate the long-term safety and effectiveness of lunsekimig in adults with moderate to severe asthma

    Recruiting

    2 1 1
    Belgium Denmark France Germany Hungary Italy +3

  • A study to evaluate the effectiveness of R2R01 in preventing acute kidney injury in patients at high risk following heart surgery.

    Recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac function disturbance postoperative
    • Acute kidney injury
    Investigated Drugs:
    • R2R01
    • Sodium Chloride
    Germany Italy

  • Comparing the effectiveness of 7 days versus 14 days of ciprofloxacin or ceftriaxone for treating kidney infection in kidney transplant recipients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pyelonephritis
    Investigated Drugs:
    • Ciprofloxacin
    • Ciprofloxacin Hydrochloride
    • Ceftriaxone
    Spain

  • A study comparing different zinc doses for the treatment of Wilson disease in healthy participants.

    Recruiting

    2 1 1
    Investigated Diseases:
    • Hepato-lenticular degeneration
    Investigated Drugs:
    • Copper (64Cu) Chloride
    • ZINC
    Denmark
Previous Page
1 … 48 49 50 51 52 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!